A clinical trial of hydroxychloroquine has been halted after the drug was deemed ‘very unlikely to be beneficial’ to COVID-19 patients - Amanda Krause · Journa

Article

Amanda Krause for Business Insider

Jun 20 ’20

A clinical trial of hydroxychloroquine has been halted after the drug was deemed ‘very unlikely to be beneficial’ to COVID-19 patients

We found this article at:

www.businessinsider.nl/hydroxychloroquine-clinical-trial-has-been-halted-2020-6/

auteur

Get notified of new articles from this auteur

Amanda Krause

Business Insider

Follow this authorFollow this author More articles